Shah Metacorp Receives Listing Approvals from BSE and NSE
Shah Metacorp received listing approvals from BSE and NSE for equity shares issued on a preferential basis, including those from a share swap.
Listing approval typically has a moderate positive impact as it increases the visibility and tradability of the company's shares.
The announcement confirms the successful listing approval from both BSE and NSE, which is a positive development for the company.
* Shah Metacorp Limited (formerly Gyscoal Alloys Limited) received listing approval from BSE on 14 Nov 2025 and NSE on 01 Dec 2025. * Approvals are for the listing of 6,65,00,000 equity shares of ₹1 each issued at a premium of ₹3.71 to Non-Promoters on a preferential basis. * Also includes listing of 18,93,32,190 equity shares of ₹1 each issued at a premium of ₹3.71 to Promoters and Non-promoters on a preferential basis pursuant to a share swap. * The exchange granted in-principle approval for listing of 25,58,32,190 Equity shares of ₹1 each allotted on preferential basis.
What to do with a filing like this
Shah Metacorp Limited filed this with the NSE as a statutory disclosure, categorised under preferential allotment. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shah Metacorp Limited. Read the original for the full detail.